Randomized Phase II, 2-arm Study of Pembrolizumab After High Dose Radiation (SBRT) Versus Pembrolizumab Alone in Patients With Advanced Non-small Cell Lung Cancer
Phase of Trial: Phase II
Latest Information Update: 18 Sep 2017
At a glance
- Drugs Pembrolizumab (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms PEMBRO-RT
- 13 Sep 2017 Planned End Date changed from 1 Oct 2016 to 1 Oct 2017.
- 13 Sep 2017 Planned primary completion date changed from 1 Oct 2016 to 1 Oct 2017.
- 15 Jul 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.